SG144944A1 - Stable modifications of tegaserod hydrogen maleate - Google Patents

Stable modifications of tegaserod hydrogen maleate

Info

Publication number
SG144944A1
SG144944A1 SG200805476-9A SG2008054769A SG144944A1 SG 144944 A1 SG144944 A1 SG 144944A1 SG 2008054769 A SG2008054769 A SG 2008054769A SG 144944 A1 SG144944 A1 SG 144944A1
Authority
SG
Singapore
Prior art keywords
hydrogen maleate
stable modifications
tegaserod hydrogen
tegaserod
stable
Prior art date
Application number
SG200805476-9A
Other languages
English (en)
Inventor
Sabine Pfeffer
Christian Vitzling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG144944(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG144944A1 publication Critical patent/SG144944A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
SG200805476-9A 2003-07-24 2004-07-23 Stable modifications of tegaserod hydrogen maleate SG144944A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48963803P 2003-07-24 2003-07-24

Publications (1)

Publication Number Publication Date
SG144944A1 true SG144944A1 (en) 2008-08-28

Family

ID=34135099

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200805476-9A SG144944A1 (en) 2003-07-24 2004-07-23 Stable modifications of tegaserod hydrogen maleate

Country Status (24)

Country Link
US (1) US20070112056A1 (ru)
EP (2) EP1651601A1 (ru)
JP (1) JP2006528609A (ru)
KR (1) KR20060040710A (ru)
CN (1) CN1826318A (ru)
AR (1) AR045081A1 (ru)
AU (1) AU2004263285A1 (ru)
BR (1) BRPI0412830A (ru)
CA (1) CA2532351A1 (ru)
CO (1) CO5680418A2 (ru)
EC (1) ECSP066306A (ru)
IL (1) IL172914A0 (ru)
IS (1) IS8321A (ru)
MA (1) MA27935A1 (ru)
MX (1) MXPA06000917A (ru)
MY (1) MY137386A (ru)
NO (1) NO20060915L (ru)
NZ (1) NZ544596A (ru)
PE (1) PE20050253A1 (ru)
RU (1) RU2349585C2 (ru)
SG (1) SG144944A1 (ru)
TN (1) TNSN06024A1 (ru)
TW (1) TW200510302A (ru)
WO (1) WO2005014544A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045120A2 (en) * 2004-10-19 2006-04-27 Teva Pharmaceutical Industries Ltd. Purification of tegaserod maleate
BRPI0606898A2 (pt) * 2005-01-31 2009-07-21 Novartis Ag uso de agonista de 5-ht4 na preparação de medicamentos e método útil no esvaziamento gástrico retardado
CZ298399B6 (cs) * 2005-05-02 2007-09-19 Zentiva, A. S. Zpusob prípravy 2-[(5-methoxy-1 H-indol-3-yl) methylen]-N-pentylkarbazimidamidu (tegaserodu)
EP1893195A2 (en) * 2005-06-22 2008-03-05 Teva Pharmaceutical Industries Ltd Polymorphic forms of tegaserod maleate
WO2007119109A2 (en) * 2005-10-06 2007-10-25 Medichem, S.A. Processes for preparing tegaserod maleate and pharmaceutical compositions containing it
GB0524668D0 (en) * 2005-12-02 2006-01-11 Novartis Ag Organic compounds
WO2007120924A1 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Preparation of tegaserod maleate free of iodide
EP1956002A1 (en) * 2007-02-07 2008-08-13 Chemo Ibérica, S.A. New tegaserod maleate polymorphs and process for their preparation
AU2008252604A1 (en) * 2007-05-17 2008-11-27 Generics [Uk] Limited Process for the preparation of form A of tegaserod

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242588A (ja) * 1988-03-25 1989-09-27 Chiba Gosei Kenkyusho:Kk 7―シアノメチルチオアセトアミド―7α―メトキシ―3―(1―メチル―1H―テトラゾール―5―イル)チオメチル―3―セフェム―4―カルボン酸の結晶及びその製造方法
HUT64023A (en) * 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
JPH08291140A (ja) * 1995-04-20 1996-11-05 Teikoku Chem Ind Corp Ltd 易吸収性結晶
CN1165293C (zh) * 1998-08-21 2004-09-08 诺瓦提斯公司 5ht4激动剂或拮抗剂的新型口服制剂
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
CN1176077C (zh) * 2003-01-07 2004-11-17 江苏省药物研究所 马来酸替加色罗一水结晶
US20050119328A1 (en) * 2003-03-25 2005-06-02 Hetero Drugs Limited Novel crysalline forms of tegaserod maleate
JP2007514000A (ja) * 2003-12-16 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド テガセロッド塩基及びその塩の多形現象形
US20050272802A1 (en) * 2004-04-22 2005-12-08 Sundaram Venkataraman Process for preparing form I of tegaserod maleate
EP1893195A2 (en) * 2005-06-22 2008-03-05 Teva Pharmaceutical Industries Ltd Polymorphic forms of tegaserod maleate

Also Published As

Publication number Publication date
US20070112056A1 (en) 2007-05-17
IL172914A0 (en) 2006-06-11
EP1880992A1 (en) 2008-01-23
AU2004263285A1 (en) 2005-02-17
MXPA06000917A (es) 2006-03-30
AR045081A1 (es) 2005-10-12
WO2005014544A1 (en) 2005-02-17
PE20050253A1 (es) 2005-06-03
NO20060915L (no) 2006-04-24
CA2532351A1 (en) 2005-02-17
KR20060040710A (ko) 2006-05-10
MY137386A (en) 2009-01-30
CO5680418A2 (es) 2006-09-29
ECSP066306A (es) 2006-07-28
JP2006528609A (ja) 2006-12-21
TW200510302A (en) 2005-03-16
BRPI0412830A (pt) 2006-09-26
MA27935A1 (fr) 2006-06-01
NZ544596A (en) 2009-01-31
IS8321A (is) 2006-02-22
TNSN06024A1 (en) 2007-10-03
RU2006105481A (ru) 2007-09-20
RU2349585C2 (ru) 2009-03-20
CN1826318A (zh) 2006-08-30
EP1651601A1 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
IL172914A0 (en) Stable modifications of tegaserod hydrogen maleate
EP1486587A4 (en) ELECTRODE FOR THE PRODUCTION OF HYDROGEN
AU2003286894A8 (en) Hydrogen generator
EP1765745A4 (en) DISSOCIATION OF MOLECULAR WATER TO MOLECULAR HYDROGEN
PL1615622T3 (pl) Preparaty doksycyklin do jednorazowego dziennego podawania
GB0325478D0 (en) Generation of documents
IL182334A0 (en) Synthesis of hydrogen peroxide
IL176424A0 (en) Preparation of tegaserod and tegaserod maleate
AU2003269638A8 (en) Hydrogen generator
GB0326768D0 (en) Generation of therapeutic microfoam
AU2003222439A1 (en) Novel crystalline forms of tegaserod maleate
AU2003229987A8 (en) Hydrogen generation
TW562258U (en) Structure of 3D inverted F-antenna
HK1087619A1 (en) Oral suspension of tegaserod
GB0217801D0 (en) Hydrogen
TW569704U (en) Improved structure of dual-liquid-type container
TW515461U (en) Improved structure of squat nightstool
TW535585U (en) Structure of love-playing chair
TW533806U (en) Structure of improved-type chair
GB0320513D0 (en) Production of hydrogen
TW558985U (en) Improved structure of hammock
TW578496U (en) Improved structure of assembled closet
GB0324738D0 (en) Personal deodorant of natural origin
GB0319898D0 (en) Alkaline - water hydrogen generator
TW551680U (en) Improved structure of telecommunication connection socket